ISIN | LU2402148576 |
---|---|
Valor Number | 114551789 |
Bloomberg Global ID | UBHPUAC LX |
Fund Name | UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) (EUR hedged) P-acc |
Fund Provider |
UBS Asset Management Switzerland AG
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Equities |
EFC Category | Equity Health Care |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Fund’s investment objective consists in generating strong capital appreciation with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. This sub-fund is a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests at least two thirds of its assets worldwide in shares or other equity interests of companies in developed or emerging markets, which mainly promote United Nations Sustainable Development Goal 3 (Good Health and Well-Being). The focus is on companies that capitalise on healthcare transformation. |
Peculiarities |
Current Price * | 94.95 EUR | 20.12.2024 |
---|---|---|
Previous Price * | 93.90 EUR | 19.12.2024 |
52 Week High * | 108.46 EUR | 30.08.2024 |
52 Week Low * | 92.11 EUR | 17.04.2024 |
NAV * | 94.95 EUR | 20.12.2024 |
Issue Price * | 94.95 EUR | 20.12.2024 |
Redemption Price * | 94.95 EUR | 20.12.2024 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 243,314,814 | |
Unit/Share Assets *** | 6,846,200 | |
Trading Information SIX |
YTD Performance | -1.35% |
29.12.2023 - 20.12.2024
29.12.2023 20.12.2024 |
---|---|---|
YTD Performance (in CHF) | -1.00% |
29.12.2023 - 20.12.2024
29.12.2023 20.12.2024 |
1 month | -2.31% |
20.11.2024 - 20.12.2024
20.11.2024 20.12.2024 |
3 months | -9.97% |
20.09.2024 - 20.12.2024
20.09.2024 20.12.2024 |
6 months | -4.65% |
20.06.2024 - 20.12.2024
20.06.2024 20.12.2024 |
1 year | +2.11% |
20.12.2023 - 20.12.2024
20.12.2023 20.12.2024 |
2 years | +5.90% |
20.12.2022 - 20.12.2024
20.12.2022 20.12.2024 |
3 years | -5.86% |
20.12.2021 - 20.12.2024
20.12.2021 20.12.2024 |
5 years | -5.05% |
24.11.2021 - 20.12.2024
24.11.2021 20.12.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UnitedHealth Group Inc | 9.85% | |
---|---|---|
Eli Lilly and Co | 9.50% | |
AstraZeneca PLC | 5.77% | |
Intuitive Surgical Inc | 5.36% | |
Koninklijke Philips NV | 4.88% | |
Sandoz Group AG Registered Shares | 4.58% | |
Chugai Pharmaceutical Co Ltd | 4.15% | |
Novartis AG Registered Shares | 4.05% | |
Bristol-Myers Squibb Co | 4.02% | |
Alcon Inc | 3.98% | |
Last data update | 30.11.2024 |
TER | 1.84% |
---|---|
TER date | 30.11.2023 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 1.41% |
Ongoing Charges *** | 1.84% |
SRRI ***
|
|
SRRI date *** |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |